423 related articles for article (PubMed ID: 21748820)
41. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
[TBL] [Abstract][Full Text] [Related]
42. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
43. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
[TBL] [Abstract][Full Text] [Related]
44. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of CD151 gene expression in non-small cell lung cancer.
Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
[TBL] [Abstract][Full Text] [Related]
46. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
[TBL] [Abstract][Full Text] [Related]
47. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
49. Isolation of miRNAs that target EGFR mRNA in human lung cancer.
Yamaguchi G; Takanashi M; Tanaka M; Fujita K; Ohira T; Kuroda M; Ikeda N
Biochem Biophys Res Commun; 2012 Apr; 420(2):411-6. PubMed ID: 22426479
[TBL] [Abstract][Full Text] [Related]
50. Characterization of melanoma-associated antigen-a genes family differential expression in non-small-cell lung cancers.
Karimi S; Mohammadi F; Porabdollah M; Mohajerani SA; Khodadad K; Nadji SA
Clin Lung Cancer; 2012 May; 13(3):214-9. PubMed ID: 22138038
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
52. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
53. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
[TBL] [Abstract][Full Text] [Related]
54. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
[TBL] [Abstract][Full Text] [Related]
55. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
[TBL] [Abstract][Full Text] [Related]
56. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
57. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.
Zhang Y; Li H; Han J; Zhang Y
Int J Clin Exp Pathol; 2015; 8(2):1967-72. PubMed ID: 25973090
[TBL] [Abstract][Full Text] [Related]
59. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
[TBL] [Abstract][Full Text] [Related]
60. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]